ADIPOQ and inherited lipid metabolism disorder: In Zucker rats, Rimonabant also reduced plasma tumour necrosis factor-alpha levels, increased the plasma adiponectin levels and improved dyslipidaemia by decreasing plasma levels of triglycerides, free fatty acids and total cholesterol, and increasing the HDL/LDL ratio.